These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences. Yu A; Street D; Viney R; Goodall S; Pearce A; Haywood P; Haas M; Battaglini E; Goldstein D; Timmins H; Park SB Support Care Cancer; 2021 Nov; 29(11):6379-6387. PubMed ID: 33884508 [TBL] [Abstract][Full Text] [Related]
3. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Kuriyama A; Endo K Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005 [TBL] [Abstract][Full Text] [Related]
4. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466 [TBL] [Abstract][Full Text] [Related]
5. Exploring Chemotherapy-Induced Peripheral Neuropathy Management Practice Patterns Among Oncology Clinicians. Kanzawa-Lee G; Krauss JC; Knoerl R Semin Oncol Nurs; 2024 Oct; 40(5):151685. PubMed ID: 38937199 [TBL] [Abstract][Full Text] [Related]
6. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy. Knoerl R; Weller E; Halpenny B; Berry D BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351 [TBL] [Abstract][Full Text] [Related]
7. Identifying trajectories and predictors of chemotherapy-induced peripheral neuropathy symptoms, physical functioning, and falls across treatment and recovery in adults treated with neurotoxic chemotherapy: the PATTERN observational study protocol (NCT05790538). Winters-Stone KM; Krasnow SM; Horak FB; Mancini M; Cameron MH; Dieckmann NF; Stoyles SA; Roeland EJ BMC Cancer; 2023 Nov; 23(1):1087. PubMed ID: 37946117 [TBL] [Abstract][Full Text] [Related]
8. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling. Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099 [TBL] [Abstract][Full Text] [Related]
9. Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices. Selvy M; Pereira B; Kerckhove N; Busserolles J; Farsi F; Guastella V; Merle P; Pezet D; Balayssac D Support Care Cancer; 2021 Jul; 29(7):4033-4043. PubMed ID: 33403401 [TBL] [Abstract][Full Text] [Related]
11. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol. Jang CE; Jung MS; Sohn EH; Kim M; Yoo HS; Bae K; Kim JR; Lee JS Trials; 2018 Sep; 19(1):526. PubMed ID: 30268158 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-Induced Peripheral Neuropathy Detection via a Smartphone App: Cross-sectional Pilot Study. Chen CS; Kim J; Garg N; Guntupalli H; Jagsi R; Griggs JJ; Sabel M; Dorsch MP; Callaghan BC; Hertz DL JMIR Mhealth Uhealth; 2021 Jul; 9(7):e27502. PubMed ID: 36260403 [TBL] [Abstract][Full Text] [Related]